Reynier J, Arkwright S, Chevalier J M, Lalo J, Gonter A, Goumot P A, Renody N, Vilde F, Villet R
Hôpital Boucicaut, Paris.
Chirurgie. 1993;119(9):477-83; discussion 484.
Modified subcutaneous mastectomy was described by one of us in 1968; its approach, the dissection of the gland, plastic reconstruction of shape and volume are completely different from the subcutaneous mastectomy performed by plastic surgeons. 3 different time periods were studied to explain clearly evolution in the technic and indications. During many years retrospective studies made it possible to build a procedure according to the new diagnostic means for infraclinical breast cancer and to the constant improving prosthetic material. Therefore our indications for modified subcutaneous mastectomy are as following: suspicious mastopathies are the best indications with a performing choice of the radiologic images which require histologic control some evolutive or evoluated mastopathies some small infiltrating tumors developing in a highly dystrophic glandular surrounding. The numerous in situ cancers accompanying them argue for this choice. some big phyllod tumors or phyllod's recurrences.
1968年我们中的一人描述了改良皮下乳房切除术；其手术方法、腺体解剖、形状和体积的整形重建与整形外科医生所做的皮下乳房切除术完全不同。我们研究了3个不同时期，以清楚地解释该技术和适应症的演变。多年来的回顾性研究使得根据亚临床乳腺癌的新诊断手段以及不断改进的假体材料制定一种手术方法成为可能。因此，我们改良皮下乳房切除术的适应症如下：可疑乳腺疾病是最佳适应症，需要对放射影像进行明智选择，并进行组织学控制，一些进展期或已进展的乳腺疾病，一些在高度营养不良的腺性组织中发生的小浸润性肿瘤。与之伴随的众多原位癌支持了这一选择。一些大的叶状肿瘤或叶状肿瘤复发。
